Research group Per Eriksson
The aim of the Ehrenborg team is to characterize physiological and molecular consequences of genetic variability in important proteins involved in the development of cardiovascular metabolic diseases and investigate the regulation of these proteins.
The long-term interest of the Eriksson team is to study the molecular mechanisms underlying aortic aneurysm.
Rachel Fisher investigates the development of cardiometabolic disease through studies of lipid metabolism in human liver and adipose tissue
The Hagberg team aims to elucidate early cellular mechanisms in our white adipose tissue that contribute to the development of obesity-induced metabolic disorders, focusing on nutrient biochemistry.
The aim of our team is to identify and understand the key immunometabolic reactions controlling inflammation in the vascular wall and to develop new therapeutic targets to prevent and treat CVD.
The major focus of the Paolino team is to explore the functions and mechanisms of ubiquitin-dependent pathways in metabolism, cancer and immunity.